• 1. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

Research Brief on 8-Fluoro-1-methylisoquinoline-6-sulfonyl Chloride (CAS: 2060029-03-8): Recent Advances and Applications

8-Fluoro-1-methylisoquinoline-6-sulfonyl chloride (CAS: 2060029-03-8) is a specialized chemical compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its versatile reactivity and potential applications in drug discovery and development. This sulfonyl chloride derivative serves as a key intermediate in the synthesis of biologically active molecules, particularly in the construction of sulfonamide-based compounds, which are widely utilized in pharmaceuticals for their diverse therapeutic properties.

Recent studies have highlighted the importance of 8-fluoro-1-methylisoquinoline-6-sulfonyl chloride in the development of novel enzyme inhibitors and receptor modulators. Its unique structural features, including the fluorine substitution and the sulfonyl chloride moiety, make it an attractive scaffold for designing compounds with enhanced binding affinity and selectivity. Researchers have employed this compound in the synthesis of targeted inhibitors for kinases, proteases, and other enzymes implicated in various diseases, such as cancer, inflammatory disorders, and infectious diseases.

One notable application of 8-fluoro-1-methylisoquinoline-6-sulfonyl chloride is in the development of fluorescent probes and imaging agents. The isoquinoline core, combined with the fluorine atom, provides favorable photophysical properties, enabling its use in bioimaging and diagnostic applications. Recent publications have demonstrated its utility in the design of turn-on fluorescent sensors for detecting specific biomolecules in cellular environments, offering new tools for studying disease mechanisms at the molecular level.

In addition to its role in medicinal chemistry, this compound has also been explored in materials science. Its sulfonyl chloride group allows for facile conjugation with polymers and other materials, making it a valuable building block for functionalized surfaces and nanomaterials. Researchers have utilized it to create advanced materials with applications in drug delivery, biosensing, and tissue engineering.

The synthesis and characterization of 8-fluoro-1-methylisoquinoline-6-sulfonyl chloride have been refined in recent years, with improvements in yield, purity, and scalability. Modern synthetic approaches, including microwave-assisted reactions and flow chemistry, have been employed to optimize its production, ensuring consistent quality for research and industrial applications. Analytical techniques such as NMR spectroscopy, mass spectrometry, and X-ray crystallography have been instrumental in confirming its structure and purity.

Future research directions for this compound include expanding its applications in targeted drug delivery systems and exploring its potential in combination therapies. The integration of computational modeling and high-throughput screening methods is expected to accelerate the discovery of new derivatives with enhanced pharmacological properties. Furthermore, ongoing studies aim to elucidate its mechanism of action in various biological systems, paving the way for innovative therapeutic strategies.

In conclusion, 8-fluoro-1-methylisoquinoline-6-sulfonyl chloride (CAS: 2060029-03-8) represents a promising chemical entity with broad applicability in chemical biology, medicinal chemistry, and materials science. Its continued exploration holds great potential for advancing drug discovery and developing cutting-edge technologies in the life sciences.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)